Tausif Butt
2021
In 2021, Tausif Butt earned a total compensation of $5.9M as Executive Vice President, Chief Operating Officer at ChemoCentryx.
Compensation breakdown
| Bonus | $335,000 |
|---|---|
| Non-Equity Incentive Plan | $180,000 |
| Option Awards | $4,856,797 |
| Salary | $488,013 |
| Other | $2,334 |
| Total | $5,862,144 |
Butt received $4.9M in option awards, accounting for 83% of the total pay in 2021.
Butt also received $335K in bonus, $180K in non-equity incentive plan, $488K in salary and $2.3K in other compensation.
Rankings
In 2021, Tausif Butt's compensation ranked 2,163rd out of 12,415 executives tracked by ExecPay. In other words, Butt earned more than 82.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,163 out of 12,415 | 83rd |
Division Manufacturing | 840 out of 5,505 | 85th |
Major group Chemicals And Allied Products | 322 out of 2,375 | 86th |
Industry group Drugs | 278 out of 2,096 | 87th |
Industry Pharmaceutical Preparations | 180 out of 1,546 | 88th |
Source: SEC filing on April 5, 2022.
Butt's colleagues
We found four more compensation records of executives who worked with Tausif Butt at ChemoCentryx in 2021.